Patient alliance concerning about suspension of Olital Tab development, demanding immediate actions

As patient advocates expressed concerns about suspension of the Olita Tab development, Hanmi Pharm, the Ministry of Food and Drug Safety(MFDS) and the Ministry of Health and Welfare(MOHW) insisted to prepare follow-up actions as soon as possible.

“Hanmi Pharm submitted a plan to suspend the development and sales of Olita Tab, a targeted therapy for terminal non-small cell lung cancer, to the M...